MD Anderson and Nature to host conference on next-generation cancer therapies
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
Six emerging cancer researchers outline in a Nature Reviews Cancer anniversary viewpoint the technologies and paradigms that will shape oncology ...
In a groundbreaking advancement poised to revolutionize the landscape of immunotherapy and vaccine development, researchers at MIT have engineered a ...
T cells stand at the forefront of the immune system’s defense, orchestrating responses that are vital in combating infections, clearing ...
In a groundbreaking study published in Nature on January 28, 2026, scientists from the Salk Institute for Biological Studies, UNC ...
Gestational trophoblastic neoplasia (GTN) presents a unique challenge within the oncology landscape, combining elements of maternal health and tumor biology. ...
In a groundbreaking advancement that promises to revolutionize the field of immunotherapy, researchers have unveiled a pioneering two-stage inertial microfluidics ...
In a groundbreaking study, researchers have unveiled PredIG, a state-of-the-art computational tool designed to predict the immunogenicity of T-cell epitopes. ...
In a groundbreaking revelation within the field of cancer therapy, researchers have pioneered a method that significantly enhances the efficacy ...
In an inspiring breakthrough in the realm of cancer therapy, recent research has unveiled a novel approach to enhancing the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine